Keyphrases
Antipsoriatic
14%
Autoimmune Skin Disorders
14%
Biochemical Markers
14%
Co-load
100%
Curcumin
100%
Distribution Studies
14%
Effective Strategies
14%
Enzyme-linked Immunosorbent Assay (ELISA)
14%
Expression Level
14%
Gel Formulation
14%
Histopathological Features
14%
Hyperproliferation
14%
Imiquimod
14%
Imiquimod Induced Psoriatic Plaque Model
14%
Interleukin-17 (IL-17)
14%
Interleukin-22 (IL-22)
14%
Keratinocytes
14%
Lipospheres
100%
Low Water Solubility
14%
Particle Size
14%
Patient Well-being
14%
Phenotypic Characteristics
14%
Poor Differentiation
14%
Psoriasis
100%
Psoriasis Treatment
14%
Psoriatic
14%
Psoriatic Skin
14%
Shear Thinning
14%
Skin Layer
14%
Skin Penetration
14%
Slow Release
14%
Synergistic Interaction
100%
Tacrolimus
100%
Therapeutic Efficacy
14%
Topical Application
14%
Topical Delivery
14%
Topical Formulation
14%
Pharmacology, Toxicology and Pharmaceutical Science
Antipsoriasis Agent
16%
Biochemical Marker
16%
Combination Therapy
16%
Curcumin
100%
Enzyme-Linked Immunosorbent Assay
16%
Imiquimod
33%
Interleukin 17
16%
Psoriasis
100%
Skin Disease
16%
Tacrolimus
100%
Tumor Necrosis Factor
16%